Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Jun 28, 2022 10:58 PM
Social Media Platform RED Expands Overseas to Southeast Asia
As the company matures and domestic market competition intensifies, more and more businesses began to seek new opportunities elsewhere. For instance, the RED plans to expand into Southeast Asia and North America.
Jun 28, 2022 06:30 PM